Dr. Marco Alejandro Gonzalez, MD

Dr. Gonzalez practices at Delray Eye Associates PA in Delray Beach, Florida.

Dr. Gonzalez's NPI, 1730322116, was assigned on April 14, 2009. Dr. Gonzalez graduated from UCSF School of Medicine in 2009. Dr. Gonzalez holds Florida license ME115882.

Dr. Gonzalez's primary practice is Delray Eye Associates PA, at 16201 S Military Trl, Delray Beach, FL 33484 in Palm Beach County. The practice phone is (561) 498-8100.

Dr. Gonzalez's primary practice is Delray Eye Associates PA in Delray Beach, Florida. Dmand AI also links Dr. Gonzalez to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gonzalez practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Gonzalez's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Gonzalez is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Gonzalez is licensed in Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, eye infection or inflammation, eyelid inflammation, glaucoma and hypertensive retinopathy among the conditions Dr. Gonzalez treats.

CMS data shows 54,361 Medicare services from Dr. Gonzalez across 29 procedure codes in 2024, for 1,648 Medicare patients. Medicare paid $4,181,006 for them.

CMS counts 1,648 Medicare patients who saw Dr. Gonzalez in 2024. The largest group is 85 and over, with 684 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gonzalez's median patient age at 83, with 60% women.

In 2024, Dr. Gonzalez wrote 569 Medicare Part D claims for 195 patients. 58% of them were for generic drugs. CMS names the drug for 480 of them, across 11 drugs with 11 or more claims each, at $46,905 in total drug cost. In 2023, CMS named 475 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gonzalez for performance year 2024, reported as part of a group. Dr. Gonzalez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 23 procedures of cataract surgery by Dr. Gonzalez, more than 47% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Gonzalez, published from 2013 to 2020. The most frequent topics are Tomography, Optical Coherence, Visual Acuity and Vitrectomy. Dr. Gonzalez has published most often in Ophthalmic Surg Lasers Imaging Retina. Dr. Gonzalez's most frequent co-authors are Thomas A. Albini, MD, Harry W. Flynn, MD and William E. Smiddy, MD.

CMS Open Payments shows 114 general payments to Dr. Gonzalez from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Carl Zeiss Meditec, Inc. paid the most, $3,000.

Dmand AI lists 1 award for Dr. Gonzalez, most recently CMS Stage 1 EHR in 2014.

Dr. Gonzalez graduated from UCSF School of Medicine in 2009.

Dr. Gonzalez is in network with 5 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.